Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: Venture
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

Arch Biopartners Inc

+ Add to Watchlist

ACH:CN

0.3100 CAD 0.0100 3.13%

As of 12:03:11 ET on 05/27/2015.

Snapshot for Arch Biopartners Inc (ACH)

Open: 0.3100 Day's Range: 0.3100 - 0.3100 Volume: 33
Previous Close: 0.3200 52wk Range: 0.1200 - 0.4200 1-Yr Rtn: +93.75%

Stock Chart for ACH

No chart data available.
  • ACH:CN 0.3100
  • 1D
  • 1M
  • 1Y
0.3200
Interactive ACH Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for ACH

Current P/E Ratio (ttm) -
Estimated P/E(-) -
Relative P/E vs. SPTSX -
Earnings Per Share (ttm) -0.0140
Est. EPS -
Est. PEG Ratio -
Market Cap (M CAD) 16.47
Shares Outstanding (M) 53.12
30 Day Average Volume 11,835
Price/Book (mrq) -
Price/Sale (ttm) 177.8527
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 05/29/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for ACH

  • Revenue
  • Net Income (M/CAD)
  • Profit Margin (%)

Company Profile & Key Executives for ACH

Arch Biopartners Inc. is a biotechnology company established to develop new products and technology for sale to pharmaceutical and industrial companies. The Company is focused on treatments for brain tumours, chronic kidney and bowel diseases caused by non-infectious inflammation, and binding of peptides to solid surfaces.

Richard G MuruvePresident/CEODaniel Abraham MuruveChief Science Officer
More Company Profile & Key Executives for ACH

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil